Le Lézard
Classified in: Health, Science and technology
Subject: Stock Sale/Buyback

Arcus Biosciences Announces New Employment Inducement Grants


Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company's Board of Directors granted four new employees options to purchase a total of 23,400 shares of the Company's common stock at an exercise price per share of $44.59, which was the closing price on December 23, 2021. The stock options were granted pursuant to the Company's 2020 Inducement Plan, which was approved by the Company's Board of Directors in January 2020 pursuant to the "inducement exception" under NYSE Listed Company Manual Rule 303A.08.

About Arcus Biosciences

Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer. In partnership with industry partners, patients and physicians around the world, Arcus is expediting the development of first- or best-in-class medicines against well characterized biology and pathways and studying novel, biology-driven combinations that have the potential to help people with cancer live longer. Founded in 2015, the company has expedited the development of six investigational medicines into clinical studies, including new combination approaches that target TIGIT, PD-1, the adenosine axis (CD73 and dual A2a/A2b) and most recently, HIF-2alfa. For more information about Arcus Biosciences' clinical and pre-clinical programs, please visit www.arcusbio.com or follow us on Twitter.

Inducement PR

Source: Arcus Biosciences


These press releases may also interest you

at 14:45
The "European Defence Training and Simulation Growth Opportunities" report has been added to  ResearchAndMarkets.com's offering. This report explores the changing trends in the European defence T&S market in light of the changing geopolitical...

at 14:36
Dr. Lisa Damour, Ph.D. will guide parents through the emotional roller coaster of the middle and high school years during a live virtual webinar Wednesday hosted by Fusion Education Group....

at 14:33
The Premise Poll, in its latest regular political tracking poll, found that by a margin of 10 points, 42% - 32%, a plurality of Americans oppose sending undocumented individuals from the U.S.-Mexico border to cities in the North.  Nearly half of...

at 14:30
Conterra Ultra Broadband Holdings, Inc. ("Conterra Networks") today announced its continued investment in fiber network growth across Bossier Parish with its initial investment of $2.6 million and an additional estimated $3.5 million expected over 5...

at 14:28
namelesstm, the company backed by Gary Vee, Mechanism Capital and Guy Oseary's Sound Ventures, among others, has just released an innovative SaaS product to improve NFT project testing and quality assurance. The new NFT software, called StealthTest,...

at 14:24
On November 1, 2022, Equature will be releasing Equature Connect; a full-scale situational awareness tool to assist all facets of public safety. Equature Connect streams live video, real-time location, and audio directly from a 9-1-1 caller's...



News published on 24 december 2021 at 16:15 and distributed by: